89 related articles for article (PubMed ID: 12616716)
21. A protein-tyrosine phosphatase with sequence similarity to the SH2 domain of the protein-tyrosine kinases.
Shen SH; Bastien L; Posner BI; Chrétien P
Nature; 1991 Aug; 352(6337):736-9. PubMed ID: 1652101
[TBL] [Abstract][Full Text] [Related]
22. Site-specific dephosphorylation and deactivation of the human insulin receptor tyrosine kinase by particulate and soluble phosphotyrosyl protein phosphatases.
King MJ; Sharma RP; Sale GJ
Biochem J; 1991 Apr; 275 ( Pt 2)(Pt 2):413-8. PubMed ID: 1850986
[TBL] [Abstract][Full Text] [Related]
23. Antitumor effects of somatostatin mediated by the stimulation of tyrosine phosphatase.
Liebow C; Lee MT; Schally A
Metabolism; 1990 Sep; 39(9 Suppl 2):163-6. PubMed ID: 1976210
[No Abstract] [Full Text] [Related]
24. Signaling and transcriptional changes critical for transformation of human cells by simian virus 40 small tumor antigen or protein phosphatase 2A B56gamma knockdown.
Moreno CS; Ramachandran S; Ashby DG; Laycock N; Plattner CA; Chen W; Hahn WC; Pallas DC
Cancer Res; 2004 Oct; 64(19):6978-88. PubMed ID: 15466190
[TBL] [Abstract][Full Text] [Related]
25. Identification, cloning, and expression of a cytosolic megakaryocyte protein-tyrosine-phosphatase with sequence homology to cytoskeletal protein 4.1.
Gu MX; York JD; Warshawsky I; Majerus PW
Proc Natl Acad Sci U S A; 1991 Jul; 88(13):5867-71. PubMed ID: 1648233
[TBL] [Abstract][Full Text] [Related]
26. Combined targeting of SET and tyrosine kinases provides an effective therapeutic approach in human T-cell acute lymphoblastic leukemia.
Richard NP; Pippa R; Cleary MM; Puri A; Tibbitts D; Mahmood S; Christensen DJ; Jeng S; McWeeney S; Look AT; Chang BH; Tyner JW; Vitek MP; Odero MD; Sears R; Agarwal A
Oncotarget; 2016 Dec; 7(51):84214-84227. PubMed ID: 27705940
[TBL] [Abstract][Full Text] [Related]
27. Protein tyrosine kinase and protein phosphatase signaling pathways regulate volume-sensitive chloride currents in a nonpigmented ciliary epithelial cell line.
Shi C; Barnes S; Coca-Prados M; Kelly ME
Invest Ophthalmol Vis Sci; 2002 May; 43(5):1525-32. PubMed ID: 11980870
[TBL] [Abstract][Full Text] [Related]
28. Immunoreceptor tyrosine-based inhibitory motif of the IL-4 receptor associates with SH2-containing phosphatases and regulates IL-4-induced proliferation.
Kashiwada M; Giallourakis CC; Pan PY; Rothman PB
J Immunol; 2001 Dec; 167(11):6382-7. PubMed ID: 11714803
[TBL] [Abstract][Full Text] [Related]
29. Protein phosphatase 2A is a critical regulator of protein kinase C zeta signaling targeted by SV40 small t to promote cell growth and NF-kappaB activation.
Sontag E; Sontag JM; Garcia A
EMBO J; 1997 Sep; 16(18):5662-71. PubMed ID: 9312025
[TBL] [Abstract][Full Text] [Related]
30. Cytokine receptor signalling.
Ihle JN
Nature; 1995 Oct; 377(6550):591-4. PubMed ID: 7566171
[TBL] [Abstract][Full Text] [Related]
31. Identification of differentially expressed genes after PPM1D silencing in breast cancer.
Pärssinen J; Alarmo EL; Khan S; Karhu R; Vihinen M; Kallioniemi A
Cancer Lett; 2008 Jan; 259(1):61-70. PubMed ID: 17977650
[TBL] [Abstract][Full Text] [Related]
32. Role of protein tyrosine kinases and phosphatases in isotype switching: crosslinking CD45 to CD40 inhibits IgE isotype switching in human B cells.
Loh RK; Jabara HH; Ren CL; Fu SM; Vercelli D; Geha RS
Immunol Lett; 1995 Feb; 45(1-2):99-106. PubMed ID: 7542629
[TBL] [Abstract][Full Text] [Related]
33. Regulation of protein serine-threonine phosphatase type-2A by tyrosine phosphorylation.
Chen J; Martin BL; Brautigan DL
Science; 1992 Aug; 257(5074):1261-4. PubMed ID: 1325671
[TBL] [Abstract][Full Text] [Related]
34. Genetic alterations and expression of the protein phosphatase 1 genes in human cancers.
Takakura S; Kohno T; Manda R; Okamoto A; Tanaka T; Yokota J
Int J Oncol; 2001 Apr; 18(4):817-24. PubMed ID: 11251179
[TBL] [Abstract][Full Text] [Related]
35. Novel and known protein tyrosine kinases and their abnormal expression in human melanoma.
Easty DJ; Ganz SE; Farr CJ; Lai C; Herlyn M; Bennett DC
J Invest Dermatol; 1993 Nov; 101(5):679-84. PubMed ID: 8228328
[TBL] [Abstract][Full Text] [Related]
36. Sodium stibogluconate is a potent inhibitor of protein tyrosine phosphatases and augments cytokine responses in hemopoietic cell lines.
Pathak MK; Yi T
J Immunol; 2001 Sep; 167(6):3391-7. PubMed ID: 11544330
[TBL] [Abstract][Full Text] [Related]
37. Expression of a truncated protein-tyrosine phosphatase mRNA in human lung.
De Vries L; Li RY; Ragab A; Ragab-Thomas JM; Chap H
FEBS Lett; 1991 May; 282(2):285-8. PubMed ID: 1645282
[TBL] [Abstract][Full Text] [Related]
38. A kinetic approach for the study of protein phosphatase-catalyzed regulation of protein kinase activity.
Wang ZX; Zhou B; Wang QM; Zhang ZY
Biochemistry; 2002 Jun; 41(24):7849-57. PubMed ID: 12056917
[TBL] [Abstract][Full Text] [Related]
39. The protein phosphatases of Synechocystis sp. strain PCC 6803: open reading frames sll1033 and sll1387 encode enzymes that exhibit both protein-serine and protein-tyrosine phosphatase activity in vitro.
Li R; Potters MB; Shi L; Kennelly PJ
J Bacteriol; 2005 Sep; 187(17):5877-84. PubMed ID: 16109928
[TBL] [Abstract][Full Text] [Related]
40. Functional validation of the anaplastic lymphoma kinase signature identifies CEBPB and BCL2A1 as critical target genes.
Piva R; Pellegrino E; Mattioli M; Agnelli L; Lombardi L; Boccalatte F; Costa G; Ruggeri BA; Cheng M; Chiarle R; Palestro G; Neri A; Inghirami G
J Clin Invest; 2006 Dec; 116(12):3171-82. PubMed ID: 17111047
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
